Search Results

There are 1298 results for: content related to: PPARα activation in portal hypertension

  1. You have free access to this content
    Activation of peroxisome proliferator-activated receptor-α in mice induces expression of the hepatic low-density lipoprotein receptor

    British Journal of Pharmacology

    Volume 155, Issue 4, October 2008, Pages: 596–605, Z Huang, X Zhou, A C Nicholson, A M Gotto Jr, D P Hajjar and J Han

    Version of Record online : 29 JAN 2009, DOI: 10.1038/bjp.2008.331

  2. You have free access to this content
    Fenofibrate and the kidney: an overview

    European Journal of Clinical Investigation

    Volume 43, Issue 5, May 2013, Pages: 522–531, Michael S. Kostapanos, Matilda Florentin and Moses S. Elisaf

    Version of Record online : 11 MAR 2013, DOI: 10.1111/eci.12068

  3. You have free access to this content
    Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate–activated protein kinase–dependent induction of orphan nuclear receptor small heterodimer partner

    Hepatology

    Volume 50, Issue 3, September 2009, Pages: 880–892, Dipanjan Chanda, Chul Ho Lee, Yong-Hoon Kim, Jung-Ran Noh, Don-Kyu Kim, Ji-Hoon Park, Jung Hwan Hwang, Mi-Ran Lee, Kyeong-Hoon Jeong, In-Kyu Lee, Gi Ryang Kweon, Minho Shong, Goo-Taeg Oh, John Y. L. Chiang and Hueng-Sik Choi

    Version of Record online : 27 APR 2009, DOI: 10.1002/hep.23049

  4. Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: The eutectic microstructure

    Journal of Pharmaceutical Sciences

    Volume 92, Issue 3, March 2003, Pages: 505–515, Devalina Law, Weili Wang, Eric A. Schmitt, Yihong Qiu, Steven L. Krill and James J. Fort

    Version of Record online : 12 DEC 2002, DOI: 10.1002/jps.10324

  5. Comparison of the Gastrointestinal Absorption and Bioavailability of Fenofibrate and Fenofibric Acid in Humans

    The Journal of Clinical Pharmacology

    Volume 50, Issue 8, August 2010, Pages: 914–921, Dr Tong Zhu, Dr Jean-Claude Ansquer, Dr Maureen T. Kelly, Dr Darryl J. Sleep and Dr Rajendra S. Pradhan

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009354995

  6. Biomolecular Chemistry of Isopropyl Fibrates

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 4, April 2012, Pages: 1555–1569, Ganesaratnam K. Balendiran, Niharika Rath, Amanda Kotheimer, Chad Miller, Matthias Zeller and Nigam P. Rath

    Version of Record online : 13 JAN 2012, DOI: 10.1002/jps.23040

  7. You have free access to this content
    Activation of PPARα inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines

    International Journal of Cancer

    Volume 123, Issue 5, 1 September 2008, Pages: 1015–1024, Katarzyna Urbanska, Paola Pannizzo, Maja Grabacka, Sidney Croul, Luis Del Valle, Kamel Khalili and Krzysztof Reiss

    Version of Record online : 10 JUN 2008, DOI: 10.1002/ijc.23588

  8. Choice of Nonionic Surfactant Used to Formulate Type IIIA Self-Emulsifying Drug Delivery Systems and the Physicochemical Properties of the Drug Have a Pronounced Influence on the Degree of Drug Supersaturation that Develops During In Vitro Digestion

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 4, April 2014, Pages: 1050–1063, Ravi Devraj, Hywel D. Williams, Dallas B. Warren, Christopher J. H. Porter and Colin W. Pouton

    Version of Record online : 27 JAN 2014, DOI: 10.1002/jps.23856

  9. Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway

    British Journal of Pharmacology

    Volume 173, Issue 6, March 2016, Pages: 1095–1109, Guang-zhong Liu, Ting-ting Hou, Yue Yuan, Peng-zhou Hang, Jing-jing Zhao, Li Sun, Guan-qi Zhao, Jing Zhao, Jing-mei Dong, Xiao-bing Wang, Hang Shi, Yong-wu Liu, Jing-hua Zhou, Zeng-xiang Dong, Yang Liu, Cheng-chuang Zhan, Yue Li and Wei-min Li

    Version of Record online : 18 FEB 2016, DOI: 10.1111/bph.13438

  10. Improving dissolution kinetics of pharmaceuticals by fluidized bed impregnation of active pharmaceutical ingredients

    AIChE Journal

    Plamen I. Grigorov, Benjamin J. Glasser and Fernando J. Muzzio

    Version of Record online : 8 JUN 2016, DOI: 10.1002/aic.15312

  11. You have free access to this content
    Mesoporous silica-based dosage forms improve release characteristics of poorly soluble drugs: case example fenofibrate

    Journal of Pharmacy and Pharmacology

    Volume 68, Issue 5, May 2016, Pages: 634–645, Jennifer B. Dressman, Elisabeth Herbert, Alena Wieber, Gudrun Birk, Christoph Saal and Dieter Lubda

    Version of Record online : 10 AUG 2015, DOI: 10.1111/jphp.12465

  12. Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function

    European Journal of Neuroscience

    Volume 33, Issue 8, April 2011, Pages: 1421–1432, Elizabeth Gray, Mark Ginty, Kevin Kemp, Neil Scolding and Alastair Wilkins

    Version of Record online : 7 MAR 2011, DOI: 10.1111/j.1460-9568.2011.07637.x

  13. Individual and Combined Effects of Peroxisome Proliferator-Activated Receptor α and γ Agonists, Fenofibrate and Rosiglitazone, on Biomarkers of Lipid and Glucose Metabolism in Healthy Nondiabetic Volunteers

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 504–513, Dr J. A. Wagner, P. J. Larson, S. Weiss, J. L. Miller, Dr T. W. Doebber, M. S. Wu, Dr D. E. Moller and Dr K. M. Gottesdiener

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004273136

  14. You have free access to this content
    Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 2, January 2016, Pages: 283–293, A. C. Cheung, L. Lapointe-Shaw, M. Kowgier, J. Meza-Cardona, G. M. Hirschfield, H. L. A. Janssen and J. J. Feld

    Version of Record online : 12 NOV 2015, DOI: 10.1111/apt.13465

  15. Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations

    International Journal of Evidence-Based Healthcare

    Volume 10, Issue 3, September 2012, Pages: 181–190, Ian Hamilton-Craig, Karam Maximilien Kostner, Stan Woodhouse and David Colquhoun

    Version of Record online : 23 AUG 2012, DOI: 10.1111/j.1744-1609.2012.00275.x

  16. Simvastatin Does Not Have a Clinically Significant Pharmacokinetic Interaction With Fenofibrate in Humans

    The Journal of Clinical Pharmacology

    Volume 44, Issue 9, September 2004, Pages: 1054–1062, Dr Arthur J. Bergman, Dr Gail Murphy, Ms Joanne Burke, Dr Jamie J. Zhao, Mr Robert Valesky, Ms Lida Liu, Dr Kenneth C. Lasseter, Dr Weili He, Dr Thomayant Prueksaritanont, Mr Yue Qiu, Dr Alan Hartford, Dr Jose M. Vega and Dr John F. Paolini

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268044

  17. New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies

    Cardiovascular Therapeutics

    Volume 33, Issue 6, December 2015, Pages: 329–337, Christelle Foucher, Patrick Aubonnet, Petr Reichert, Mario Berli, Axel Schaeffer, Cesar Gonzalo Calvo Vargas, Anna Lochocka, Dmitry Belenky, Hans-Friedrich Koch and for the Cholib study Investigators

    Version of Record online : 2 NOV 2015, DOI: 10.1111/1755-5922.12148

  18. Chronic oral administration of low-dose combination of fenofibrate and rosuvastatin protects the rat heart against experimentally induced acute myocardial infarction

    Fundamental & Clinical Pharmacology

    Volume 30, Issue 5, October 2016, Pages: 394–405, Monika Garg, Deepa Khanna, Sanjeev Kalra and Pitchai Balakumar

    Version of Record online : 9 JUN 2016, DOI: 10.1111/fcp.12204

  19. In Situ Lipolysis and Synchrotron Small-Angle X-ray Scattering for the Direct Determination of the Precipitation and Solid-State Form of a Poorly Water-Soluble Drug During Digestion of a Lipid-Based Formulation

    Journal of Pharmaceutical Sciences

    Jamal Khan, Adrian Hawley, Thomas Rades and Ben J. Boyd

    Version of Record online : 11 SEP 2015, DOI: 10.1002/jps.24634

  20. You have free access to this content
    Fenofibrate inhibits reactive amyloidosis in mice

    Arthritis & Rheumatism

    Volume 46, Issue 6, June 2002, Pages: 1683–1688, Takehiro Murai, Toshiyuki Yamada, Takashi Miida, Katsumitsu Arai, Naoto Endo and Tadamasa Hanyu

    Version of Record online : 6 JUN 2002, DOI: 10.1002/art.10327